Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04335110 · ClinicalTrials.gov registry record · NA

Assessing Acceptability, Cost, and Efficacy of STELLA-Support Via Technology

A NA study, sponsored by Oregon Health and Science University.

Completed
Registry status
NA
Development phase
28
Enrollment target

NCT04335110 is a NA study that has completed, run by Oregon Health and Science University. The registered enrollment target is 28 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04335110, a NA study, has completed, sponsored by Oregon Health and Science University.

COMPLETED
Registry status
NA
Development phase
28 participants
Enrollment target

Study Summary

STELLA (Support via Technology Living and Learning with Advancing Alzheimer's disease and related dementias) is a multicomponent video-conference based intervention that aims to help family members caring for persons of dementia as well the person with dementia. The goal of this intervention is to reduce upsetting behaviors and care partner burden. Caring for a family member with Alzheimer's disease or related dementia (ADRD) can come with many burdens that affect not only the care partners' physical and psychological health but also barriers to access. Due to factors such as distance and cost, Internet-based interventions like STELLA are a great alternative to in-person interventions because it can still address the specific needs of families living with dementia. The hypothesis of this study is that care partners will show significant improvements in burden and depression following the intervention. STELLA is also designed to facilitate effective management of behavioral and psychological symptoms of dementia (BPSD). To accomplish this, up to 40 care partners and their 40 care recipients with Alzheimer's disease and related dementias will participate in an 8-week intervention with the support of a Guide (e.g. nurse or social worker). However, the primary focus of this study is on care partners. With the support of a Guide, care partners will identify strategies to address upsetting behaviors in the moderate to late stages of dementia. More specifically, a Guide will help care partners identify and modify distressing behavioral symptoms of dementia. Based on quantitative and qualitative approaches, the effect of the intervention on care partner affective symptoms, including depression and burden, as well as quality of life for both the care partner and the person with dementia will be assessed.

Interventions

  • BEHAVIORAL STELLA (Support via TEchnology: Living and Learning with Advancing Alzheimer's disease and related dementias)

Trial Details

FieldValue
Enrollment Target 28 participants
Start Date 2021-03-24
Est. Completion 2023-06-15
Phase NA

What the Registry Record Tells You About NCT04335110

The ClinicalTrials.gov registry entry for NCT04335110 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which STELLA (Support via TEchnology: Living and Learning with Advancing Alzheimer's disease and related dementias) is the first listed.

NCT04335110 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04335110 about?

NCT04335110 is a clinical study titled "Assessing Acceptability, Cost, and Efficacy of STELLA-Support Via Technology". STELLA (Support via Technology Living and Learning with Advancing Alzheimer's disease and related dementias) is a multicomponent video-conference based intervention that aims to help family members caring for persons of dementia as well the person with dementia. The goal of this intervention is to r...

What is the current status of trial NCT04335110?

This trial is currently completed. It is a NA study. The enrollment target is 28 participants. The study started on 2021-03-24. Estimated completion is 2023-06-15.

What interventions are being tested in trial NCT04335110?

The interventions under investigation include: STELLA (Support via TEchnology: Living and Learning with Advancing Alzheimer's disease and related dementias) (BEHAVIORAL).

Who is sponsoring clinical trial NCT04335110?

This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.